Bone loss in chronic kidney disease: Quantity or quality?

Bone. 2016 Jun:87:57-70. doi: 10.1016/j.bone.2016.03.017. Epub 2016 Apr 2.

Abstract

Chronic kidney disease (CKD) patients experience bone loss and fracture because of a specific CKD-related systemic disorder known as CKD-mineral bone disorder (CKD-MBD). The bone turnover, mineralization, and volume (TMV) system describes the morphological bone lesions in renal osteodystrophy related to CKD-MBD. Bone turnover and bone volume are defined as high, normal, or low, and bone mineralization is classified as normal or abnormal. All types of bone histology related to TMV are responsible for both bone quantity and bone quality losses in CKD patients. This review focuses on current bone quantity and bone quality losses in CKD patients and finally discusses potential therapeutic measures.

Keywords: Bone quantity and bone quality losses; Bone remodeling; Chronic kidney disease–mineral bone disorder (CKD–MBD); Vitamin D therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Bone Density
  • Bone Remodeling
  • Bone Resorption / complications*
  • Bone Resorption / pathology*
  • Bone Resorption / physiopathology
  • Bone Resorption / therapy
  • Cellular Microenvironment
  • Humans
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / pathology*
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / therapy

Substances

  • Biomarkers